Jump to content

Recommended Posts

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Similar Topics

    • By NASA
      NASA’s SpaceX Crew-11 Prelaunch News Conference
    • By NASA
      NASA Astronaut Kate RubinsNASA NASA astronaut and microbiologist Kate Rubins retired Monday after 16 years with the agency. During her time with NASA, Rubins completed two long-duration missions aboard the International Space Station, logging 300 days in space and conducting four spacewalks.
       
      “I want to extend my sincere gratitude to Kate for her dedication to the advancement of human spaceflight,” said Steve Koerner, acting director of NASA’s Johnson Space Center in Houston. “She is leaving behind a legacy of excellence and inspiration, not only to our agency, but to the research and medical communities as well. Congratulations, Kate, on an extraordinary career.”
       
      Rubins’ first mission to the orbiting laboratory began in July 2016, aboard the first test flight of the new Soyuz MS spacecraft. As part of Expedition 48/49, she contributed to more than 275 scientific experiments, including molecular and cellular biology research, and she was the first person to sequence DNA in space. Her work enabled significant advances with in-flight molecular diagnostics, long-duration cell culture, and the development of molecular biology tools and processes, such as handling and transferring small amounts of liquids in microgravity. Rubins also led the integration and deployment of biomedical hardware aboard the space station, supporting crew health and scientific research in space and on Earth.
       
      She again launched in October 2020, aboard a Soyuz spacecraft from the Baikonur Cosmodrome in Kazakhstan, taking part in Expedition 63/64. Alongside her crewmates, Rubins spent hundreds of hours working on new experiments and furthering research investigations conducted during her mission, including heart research and multiple microbiology studies. She also advanced her work on DNA sequencing in space, which could allow future astronauts to diagnose illness or identify microbes growing aboard the station or during future exploration missions.
       
      “From her groundbreaking work in space to her leadership on the ground, Kate has brought passion and excellence to everything she’s done,” said Joe Acaba, chief of the Astronaut Office at NASA Johnson. “She’s been an incredible teammate and role model. We will miss her deeply, but her impact will continue to inspire.”
       
      In addition to her flight assignments, Rubins served as acting deputy director of NASA’s Human Health and Performance Directorate, where she helped guide strategy for crew health and biomedical research. More recently, she contributed to developing next-generation lunar spacesuits, helping prepare for future Artemis missions to the Moon.
       
       
      Before her selection as an astronaut in 2009, Rubins received a bachelor’s degree in molecular biology from the University of California, San Diego, and a doctorate in cancer biology from Stanford University Medical School’s Biochemistry Department and Microbiology and Immunology Department. After returning from her second space mission, Rubins commissioned as a major in the U.S. Army Reserve, serving as a microbiologist in the Medical Service Corps. She currently holds the role of innovation officer with the 75th U.S. Army Reserve Innovation Command’s MedBio Detachment, headquartered in Boston. 


      A frequent keynote speaker at scientific, educational, and industry events on space biology, biomedical engineering, and human exploration, Rubins has advocated for NASA’s scientific and exploration missions. As she transitions from government service, she remains committed to advancing innovation at the intersection of biology, technology, and space.
       
      “It has been the honor of a lifetime to live and work in space,” said Rubins. “I am grateful for the extraordinary advances at NASA, and it was a privilege to serve and contribute to something so meaningful. The mission of exploration continues, and I can’t wait to watch this nation do what once seemed impossible.”
       

      Learn more about how NASA explores the unknown and innovates for the benefit of humanity at:
      https://www.nasa.gov/
      -end-
      Raegan Scharfetter
      Johnson Space Center, Houston
      281-910-4989
      raegan.r.scharfetter@nasa.gov

      View the full article
    • By NASA
      A SpaceX Falcon 9 rocket, with the company’s Dragon spacecraft, stands in a vertical position at Space Launch Complex 40 at Cape Canaveral Space Force Station in Florida on Tuesday, March 19, 2024.SpaceX Media accreditation is open for the next launch to deliver NASA science investigations, supplies, and equipment to the International Space Station. This launch is the 33rd SpaceX commercial resupply services mission to the orbital laboratory for NASA and will liftoff on the company’s Falcon 9 rocket.
      NASA and SpaceX are targeting no earlier than Thursday, Aug. 21, to launch the SpaceX Dragon spacecraft from Space Launch Complex-40 at Cape Canaveral Space Force Station in Florida.
      Credentialing to cover prelaunch and launch activities is open to U.S. media. The application deadline for U.S. citizens is 11:59 p.m. EDT, Sunday, Aug. 3. All accreditation requests must be submitted online at:
      https://media.ksc.nasa.gov
      Credentialed media will receive a confirmation email upon approval. NASA’s media accreditation policy is available online. For questions about accreditation, or to request special logistical support, email: ksc-media-accreditat@mail.nasa.gov. For other questions, please contact NASA’s Kennedy Space Center newsroom at: 321-867-2468.
      Para obtener información sobre cobertura en español en el Centro Espacial Kennedy o si desea solicitor entrevistas en español, comuníquese con Antonia Jaramillo o Messod Bendayan a: antonia.jaramillobotero@nasa.gov o messod.c.bendayan@nasa.gov.
      Each resupply mission to the station delivers scientific investigations in the areas of biology and biotechnology, Earth and space science, physical sciences, and technology development and demonstrations. Cargo resupply from U.S. companies ensures a national capability to deliver scientific research to the space station, significantly increasing NASA’s ability to conduct new investigations aboard humanity’s laboratory in space.
      In addition to food, supplies, and equipment for the crew, Dragon will deliver several new experiments, including bone-forming stem cells for studying bone loss prevention and materials to 3D print medical implants that could advance treatments for nerve damage on Earth. Dragon also delivers bioprinted liver tissue to study blood vessel development in microgravity and supplies to 3D print metal cubes in space.
      For almost 25 years, humans have continuously lived and worked aboard the International Space Station, advancing scientific knowledge and demonstrating new technologies that enable us to prepare for human exploration of the Moon as we prepare for Mars.
      Learn more about NASA’s commercial resupply missions at:
      https://www.nasa.gov/station
      -end-
      Claire O’Shea
      Headquarters, Washington
      202-358-1100
      claire.a.o’shea@nasa.gov
      Stephanie Plucinsky / Steven Siceloff / Danielle Sempsrott
      Kennedy Space Center, Fla.
      321-876-2468
      stephanie.n.plucinsky@nasa.gov / steven.p.siceloff@nasa.gov / danielle.c.sempsrott@nasa.gov
      Sandra Jones
      Johnson Space Center, Houston
      281-483-5111
      sandra.p.jones@nasa.gov
      Share
      Details
      Last Updated Jul 25, 2025 LocationNASA Headquarters Related Terms
      International Space Station (ISS) Commercial Resupply View the full article
    • By NASA
      JAXA (Japan Aerospace Exploration Agency)/Takuya Onishi In this photo from June 28, 2025, Expedition 73 flight engineer Jonny Kim and former NASA astronaut and director of human spaceflight at Axiom Space Peggy Whitson work together inside the International Space Station’s Destiny laboratory module setting up hardware for cancer research.
      The hardware is used to culture patient-derived cancer cells, model their growth in microgravity, and test a state-of-the-art fluorescence microscope. Results of this study may lead to earlier cancer detection methods, development of advanced cancer treatments, and promote future stem cell research in space.
      Whitson returned to Earth on July 15, 2025, with fellow Axiom Mission 4 crew members ISRO (Indian Space Research Organisation) astronaut Shubhanshu Shukla, ESA (European Space Agency) project astronaut Sławosz Uznański-Wiśniewski of Poland, and Hungarian to Orbit (HUNOR) astronaut Tibor Kapu of Hungary. They completed about two and a half weeks in space.
      Image credit: JAXA (Japan Aerospace Exploration Agency)/Takuya Onishi
      View the full article
    • By European Space Agency
      With launch slated for August, the first MetOp Second Generation satellite, MetOp-SG-A1, which also carries the Copernicus Sentinel-5 mission, is currently undergoing final preparations for liftoff aboard an Ariane 6 rocket from Europe’s Spaceport in French Guiana.
      View the full article
  • Check out these Videos

×
×
  • Create New...